SureTrader
Home > Boards > US OTC > Biotechs > CYTODYN INC (CYDY)

Actually, it was the opposite. The rationale

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BlackDoggie Member Profile
 
Followed By 8
Posts 532
Boards Moderated 0
Alias Born 02/17/17
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:04:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:04:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:02:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:01:53 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/14/2018 12:22:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/13/2018 4:38:32 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/7/2018 4:53:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/7/2018 4:34:05 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/31/2018 4:43:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/31/2018 4:38:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2018 4:34:56 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/25/2018 4:35:52 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/23/2018 8:14:51 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/23/2018 8:03:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/23/2018 7:51:29 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/10/2018 5:01:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/10/2018 4:56:01 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/8/2018 4:37:58 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/8/2018 4:36:15 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 12/29/2017 5:18:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/29/2017 5:13:14 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 12/21/2017 4:30:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/21/2017 6:06:16 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 12/15/2017 7:37:52 AM
BlackDoggie   Friday, 11/10/17 11:02:37 AM
Re: trding post# 18093
Post # of 20084 
Actually, it was the opposite. The rationale was that 30 would give statistical significance, but not clinical significance. That's a BS answer, because they would/should have known the number they (FDA) would need up front for either. Something changed in the ask - from one side or the other - in my opinion.

And again, the data was still blinded, so there's no way that the FDA looked at the data and decided they needed more.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist